New Haven, CT –– Now entering its 2nd year, the Blavatnik Fellowship at the Office of Cooperative Research is accepting applications to fill four slots for the 2019-2020 cycle. Applications will be accepted through March 1, 2019.
The Blavatnik Fellowship at Yale is designed to identify promising scientists and business people with a passion for biomedical entrepreneurship, to provide a hands-on experience for building their entrepreneurial skills, while simultaneously providing mentorship and professional development responsibilities. The fellowship seeks to engage a small number of highly-talented young professionals in new venture concepts being advanced across the life science spectrum, working alongside a wide range of world-renowned scientists, investors, entrepreneurs, and other domain experts. This is a one-year fellowship.
“The fellowship is a fairly unique experience at Yale. It is very fast-paced, providing broad exposure to some of the best therapeutic ideas coming from the faculty,” said James G. Boyle, Director of the Faculty Entrepreneurship Program. “It is also geared towards providing skill-building in a number of disciplines, with modules in licensing, negotiations, venture capital, regulatory affairs, presentation skills, and intellectual property. But probably the most important aspect of the fellowship is visibility both on and off campus. Fellows become highly networked with professionals from all across the biotech industry.”
Benefits of the fellowship include:
- Blavatnik Fellows will receive professional development in a number of key disciplines including licensing, IP, venture capital and more
- Exposure to a wide variety of new healthcare technologies with commercial applications
- Work side-by-side with experienced biopharma executives serving as entrepreneurs-in-residence
- Opportunities to pitch new venture concepts to leading venture capital groups
- Rapid expansion of one’s personal networks of industry experts
- Leadership training in selecting and managing PhD/MBA/MD students as associates
“The Blavatnik Fellowship gave me the opportunity to think beyond just science, by translating what I learned in biotech and applying it to help Yale’s brightest faculty position their technologies for investment as new ventures,” said Tim Siegert, current Blavatnik Fellow. “Every day I get to contribute to the frenzy of innovation taking place across all Yale’s campuses. It has been an exciting collaboration with faculty, OCR, venture capital and seasoned entrepreneurs, all of whom have taken the time to provide mentorship.”
In addition to attending and presenting at conferences throughout the country, the fellows will have the opportunity to learn the fundamentals of entrepreneurship. Since entrepreneurs play a crucial role in the successful commercialization of new biomedical technologies, the Blavatnik Fellowship in Life Science Entrepreneurship is designed to foster entrepreneurial skills in the life sciences, linking emerging business leaders with breakthrough innovations from across Yale University.
“The fellowship is serving as an amazing launchpad for my career, gaining exposure and experience in all facets of building new biotech companies from the ground up,” Siegert said. “Most importantly, it is rewarding to know I am playing an integral role in helping great science reach patients in need.”
The Blavatnik Fellowship program is made possible by a $15 million gift from the Blavatnik Family Foundation to expand the fund for innovation in the life sciences at Yale University.